Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt
RésuméHepatitis B and C virus infections are common serious complications of blood transfusion. Over a 6-month period in 2007/08 all samples from a blood bank in Alexandria, Egypt [n=3420] were tested for hepatitis B surface antigen [HBsAg] and anti-hepatitis C virus [HCV] antibodies. A total of 119 donors [3.5%] were positive for anti-HCV and 47 [1.4%] for HBsAg. The mean age of HCV - positive donors was significantly higher than HBV-positive donors: 35.7 [SD 83] versus 29.9 [SD 7.4] years, HCV and HBV prevalence was highest among males [93.3% and 93.6% respectively], in urban areas [66.4% and 80.9%] and among manual workers [64.7% and 46.8%]. The rates were lower than previous studies in Egypt, perhaps due to predonation screening which excludes those known to be at high risk of contracting bloodborne infections or who had other contraindications to blood donation
Wasfi, O.A.S. & Sadek, N.A. (2011). Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt. http://www.who.int/iris/handle/10665/118109
EMHJ - Eastern Mediterranean Health Journal, 17 (3), 238-242, 2011
MétadonnéesAfficher la fiche complète
Affichage des documents associés par titre, auteur, créateur et sujet.
Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria Egah, D.Z.; Banwat, E.B.; Audu, E.S.; Iya, D.; Mandong, B.M.; Anele, A.A.; Gomwalk, N.E. (2007)We investigated the seroprevalence of human immunodeficiency virus [HIV], hepatitis B virus [HBV] and hepatitis C virus [HCV] infection among 258 clergymen-in-training [age range 18-39 years] who represented a donor population that fulfilled the criteria for safe blood transfusion. In all, 15.1% of the men were positive for HBsAg, 4.3% were positive for anti-HCV and 2.7% were HIV- positive; 22.1% were infected with at least one of these viruses. Co-infection with HIV and HBV was found in 0.4% of the subjects, HBV and HCV in 0.4%, and HIV and HCV ...
Kazemi, A.; Koosha, A.; Rafizadeh, B.; Mousavinasab, N.; Mahram, M. (2008)The duration of protection after hepatitis B vaccination in children is unknown. We determined the serum level of antibody to hepatitis B surface antigen [anti-HBsAg] in 273 randomly selected 7-9-year-old schoolchildren from Zanjan City, Islamic Republic of Iran, who had been fully vaccinated against hepatitis B starting at birth. Titres </= 10 mIU/mL were considered unprotective. Just over half of the children [52%] had titres </= 10 mIU/mL with no difference between the sexes, while 81 [29.7%] had no anti-HBsAg [0 mIU/mL]. Three of the children ...
Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran Ghavanini, A.A.; Sabri, M.R. (2000)We determined the prevalence rate of hepatitis B surface antigen [HBsAg] and anti-hepatitis C virus antibodies [anti-HCV] among 7897 healthy voluntary blood donors in Shiraz, Islamic Republic of Iran. Sera were examined for HBsAg and anti-HCV antibodies using a second-generation enzyme-linked immunosorbent assay. Positive sera for HBsAg were found in 85 [1.07%] of the individuals and anti-HCV antibodies were found in 47 [0.59%]. We compared our results with those of other studies and conclude that the prevalence rate of HBsAg in our area has ...